NetScientific plc
("NetScientific", the "Group" or the "Company")
Issue of Equity
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation group, announces the issue of shares.
As announced on 20 December 2021, the Company issued 146,542 shares as part of the consideration of £192,390 for the acquisition of the majority stake in Cetromed Limited.
An application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective, and trading will commence at 8.00 a.m. on 30 December 2021. Following Admission, the total number of Ordinary Shares in issue, and therefore the total number of voting rights, will be 21,121,853.
For more information, please contact:
| NetScientific | Via Walbrook PR |
| Ilian Iliev, CEO |
|
|
|
|
| WH Ireland (NOMAD, Financial Adviser and Broker) |
|
| Chris Fielding / Darshan Patel | +44 (0)20 7220 1666 |
|
|
|
| Walbrook PR |
|
| Nick Rome/ Paul McManus/ Nicholas Johnson | 07748 325 236, 07980 541 893 or 07884 664 686 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
